On Friday, only one week after obtaining a federal green light from Pfizer and BioNTech’s COVID-19 vaccine, the Food and Drug Administration officially approved a second emergency vaccine—this one produced by Moderna. The vaccine produced by Moderna, whose headquarters in Cambridge, Mass., has been given an immediate usage permit by federal regulators. The vaccine produced by Moderna, whose headquarters in Cambridge, Mass., has been given an immediate usage permit by federal regulators. FDA Authorizes Moderna COVID-19 Vaccine For Emergency Use: Coronavirus Changes Food and Drug Administration greenlights the U.S. biomedical firm’s emergency vaccine. The step bolsters a massive inoculation campaign already underway.With last week’s Pfizer vaccine permit, health and defense authorities have undertaken a vast campaign to deliver millions of doses throughout the world. Amid the flurry accompanying the rollout of the Pfizer vaccine, Moderna’s alternative made steady headway in its drive toward a permission.

Reference
Moderna’s COVID-19 Vaccine Becomes 2nd To Earn FDA Authorization.https://www.npr.org/sections/coronavirus-live-updates/2020/12/18/947948227/modernas-covid-19-vaccine-becomes-2nd-to-earn-fda-authorization?refresh=true